Medication info

Winneup Injection

Prescription medicationSolutionInjection
Ingredient · strength
Glucose Monohydrate›462gL-Isoleucine›6gL-Leucine›7.3gL-Methionine›4gL-Phenylalanine›5.6gL-Threonine›4.2gL-Tryptophan›1.8gL-Valine›5.8gL-Arginine›11.5gL-Histidine›4.8gL-Alanine›20.7gGlycine›10.3gL-Proline›6.8gL-Serine›5gL-Tyrosine›0.4gL-Lysine Hydrochloride›7.25gMagnesium Sulfate Heptahydrate›2.47gSodium Acetate Hydrate›5.62gSodium Glycerophosphate Pentahydrate›5.92gCalcium Chloride Hydrate›0.74gPotassium Chloride›4.48gZinc Sulfate Heptahydrate›0.023gRefined Soyabean Oil›60gTriglycerides Medium-Chain›50gPurified Olive Oil›50gPurified Fish Oil (High Dose Omega-3 Fatty Acids)›40g
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
This medicine consists of three compartments divided by an internal white and external package, with oxygen-absorbing agent pouches in between. Each compartment contains a dextrose solution, an amino acid and electrolyte solution, and
Packaging
736mL (Solution A 222mL, Solution B 374mL, Solution C 140mL) / bag, 1085mL (Solution A 328mL, Solution B 551mL, Solution C 206mL) / bag, 1435mL (Solution A 433mL, Solution B 729mL, Solution C 273mL) / bag, 1820mL (Solution A 550mL, Solution B 924mL, Solution C 346mL) / bag
Approval status
Active

MFDS item code 201309522 · Approved 2013.09.30 · Insurance code 678900980,678900981,678900982,678900984

Summary

Main use
Improvement of inadequate nutritional intake (including fluids, electrolytes, and amino acids)
Who receives it
Adults · Children
Adult administration
The dose and infusion rate are determined according to the patient's ability to clear fat, metabolize nitrogen and glucose, and nutritional requirements; the dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day as nitrogen (0.6-0.9 g/kg as amino acids) - Patients experiencing moderate to high metabolic stress, regardless of nutritional status: 0.15-0.25 g/kg/day as nitrogen (0.9-1.6 g/kg as amino acids) In very special cases (e.g., burns or pronounced anabolic states), the nitrogen requirement may be higher. Dose A daily dose of 13-31 mL/kg of this drug corresponds to 0.11-0.25 g/kg of nitrogen and total calories of 14-34 kcal/kg (12-28 kcal/kg non-protein calories). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 2.0 mL/kg per hour (equivalent to glucose 0.25 g/kg, amino acids 0.10 g/kg, and fat 0.08 g/kg). The recommended infusion period is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides 0.28 g/kg of nitrogen (1.8 g/kg as amino acids), 4.5 g/kg of glucose, 1.33 g/kg of fat, and total calories of 39 kcal/kg (equivalent to 31 kcal/kg as non-protein calories). Administration Administer by intravenous infusion through a central vein.
Child administration
Use in children is not recommended.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of inadequate nutritional intake (including fluids, electrolytes, and amino acids)

View approved original text

This medicine supplies necessary fluids, electrolytes, amino acids, calories, essential fatty acids, and omega-3 fatty acids to patients for whom oral or gastrointestinal nutritional supply is difficult, thereby helping to maintain normal body function. This improves the patient's nutritional state and supports recovery. Therefore, it is used for intravenous nutrition in such cases.

How it is given

Adult administration

The dose and infusion rate are determined according to the patient's ability to clear fat, metabolize nitrogen and glucose, and nutritional requirements; the dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day as nitrogen (0.6-0.9 g/kg as amino acids) - Patients experiencing moderate to high metabolic stress, regardless of nutritional status: 0.15-0.25 g/kg/day as nitrogen (0.9-1.6 g/kg as amino acids) In very special cases (e.g., burns or pronounced anabolic states), the nitrogen requirement may be higher. Dose A daily dose of 13-31 mL/kg of this drug corresponds to 0.11-0.25 g/kg of nitrogen and total calories of 14-34 kcal/kg (12-28 kcal/kg non-protein calories). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 2.0 mL/kg per hour (equivalent to glucose 0.25 g/kg, amino acids 0.10 g/kg, and fat 0.08 g/kg). The recommended infusion period is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides 0.28 g/kg of nitrogen (1.8 g/kg as amino acids), 4.5 g/kg of glucose, 1.33 g/kg of fat, and total calories of 39 kcal/kg (equivalent to 31 kcal/kg as non-protein calories). Administration Administer by intravenous infusion through a central vein.

Child administration

Use in children is not recommended.

Precautions

This medicine should only be used according to a doctor's instructions, and if sudden allergic reactions such as fever, chills, rash, or breathing difficulties occur during use, administration must be stopped immediately. It should not be co-administered with other medications containing calcium via the vein, and the infusion line must be thoroughly cleaned. Particular caution is advised when using this medication in premature infants or low-birth-weight infants as it may pose risks. Patients allergic to fish, eggs, soybeans, peanuts, or those with severe liver, kidney, or blood disorders should not use this medication. Additionally, patients in acute shock or those with uncontrolled hyperglycemia should avoid administration. When administering this medication, the patient's condition must be carefully monitored, and blood electrolyte and fluid status should be checked regularly. Care must be taken in patients with lipid metabolism disorders, hyperlipidemia, or diabetes. In instances of overdose, symptoms such as fatty liver syndrome, amino acid excess, and hyperglycemia may occur, so the rate and dosage must be strictly controlled. This medication contains soybean oil, fish oil, and egg yolk lecithin, which can rarely cause allergic reactions, thus patients with a history of allergies should exercise caution. To prevent infection during administration, aseptic conditions should be maintained, the infusion site should be checked frequently, and regular blood tests and liver function tests should be conducted during long-term administration. Women who are pregnant or breastfeeding must carefully consider the safety of this medication in consultation with their doctor if necessary. This medication should be stored in a sealed container to prevent air and moisture ingress, and it is recommended to keep it at room temperature between 1°C and 25°C. This helps to maintain the drug's effectiveness and prevent deterioration.

Side effects

  • Dizziness
  • abdominal pain
  • upper abdominal pain
  • dry mouth
  • dyspepsia
  • black stools
  • nausea
  • vomiting
  • increased serum creatine phosphokinase
  • increased serum lactate dehydrogenase
Show 14 more
  • penile swelling
  • chest discomfort
  • peripheral edema
  • fever
  • surgical site pain
  • pruritus
  • hyperlipidemia
  • retching
  • chills
  • sweating
  • elevated body temperature
  • hyperglycemia
  • allergic reaction
  • increased C-reactive protein (CRP)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture ingress, preferably at room temperature between 1°C and 25°C. This helps to maintain the effectiveness of the drug and prevent deterioration.

Appearance and packaging

Appearance

This medicine consists of three compartments divided by an internal white and external package, with oxygen-absorbing agent pouches in between. Each compartment contains a dextrose solution, an amino acid and electrolyte solution, and

Package unit

736mL (Solution A 222mL, Solution B 374mL, Solution C 140mL) / bag, 1085mL (Solution A 328mL, Solution B 551mL, Solution C 206mL) / bag, 1435mL (Solution A 433mL, Solution B 729mL, Solution C 273mL) / bag, 1820mL (Solution A 550mL, Solution B 924mL, Solution C 346mL) / bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.